Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases
Frontiers in Drug Delivery · 26.08.2025 · 5
DOI: 10.3389/fddev.2025.1644633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Drug Delivery, online erschienen am 26.08.2025. Verfasst von Xiaopei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Key Laboratory of Medical and Health Textile Materials, Collaborative Innovation Center for Eco-textiles of Shandong Province and the Minist…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The blood-brain barrier (BBB) restricts development of drug delivery systems for brain, which hinders the potential applications of numerous pharmaceutical agents for treating central nervous system (CNS) diseases. A number of drug delivery systems have been developed to enhance the capacity of drugs to cross BBB. A detailed introduction of the structure and function of BBB was given based on the mechanism of BBB, while comparing with the pathological changes of BBB in neurodegenerative diseases (NDDs), including activation of endothelial cells, the loose of tight junction and increase of BBB permeability. The liposomes, polymer nanoparticles and other novelty approaches for treating NDDs were summarized. Here, we provide a novel perspective to classify the strategies of drug delivery system as passive targeting and active targeting according to their mechanisms. The potential of clinical translational for drug delivery systems in NDDs was explored and underscored the imperative of safety and verification through clinical trials. In summary, this review proposed current developments of drug delivery systems and discussing the potentials of drug delivery systems in clinical translational which bring new breakthroughs for treating NDDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Key Laboratory of Medical and Health Textile Materials, Collaborative Innovation Center for Eco-textiles of Shandong Province and the Ministry of Education, College of Textiles and Clothing, Qingdao University,…
- Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University, Qingdao, China.
- Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, X., Fu, M., Wang, Y., & Wu, T. (2025). Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases. Frontiers in Drug Delivery, 5. https://doi.org/10.3389/fddev.2025.1644633
Vancouver
Zhang X, Fu M, Wang Y, Wu T. Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases. Frontiers in Drug Delivery. 2025;5. doi:10.3389/fddev.2025.1644633
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaopei and Fu, Manfei and Wang, Yuanfei and Wu, Tong},
title = {Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases},
journal = {Frontiers in Drug Delivery},
year = {2025},
volume = {5},
doi = {10.3389/fddev.2025.1644633}
}
EUVIMED